|
Eloralintide Clinical Trials
5 actively recruiting trials across 4 locations
▼ -1 trial since September 2026
Also known as: LY3841136
Pipeline
Phase 2: 1Phase 3: 4
Top Sponsors
- Eli Lilly and Company5
Birmingham, Alabama2 trials
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Birmingham Clinical Research
Phase 3
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Birmingham Clinical Research
Phase 3
Mobile, Alabama1 trial
Tuscaloosa, Alabama1 trial
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
MFA Clinical Research
Phase 3
Chandler, Arizona1 trial
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.